Microbot Medical adds Sanmina manufacturing capacity for LIBERTY - 2026-06-30 - Production Milestone - Microbot Medical signed a letter of agreement with Sanmina to manufacture the FDA-cleared LIBERTY Endovascular Robotic System. Microbot framed the agreement as a second manufacturing site and capacity expansion. The… - source: globenewswire.com
Microbot Medical expands LIBERTY commercial footprint to seven Eastern U.S. states - 2026-06-23 - Market Signal - Microbot said the system spans multiple hospitals and specialty centers serving Pennsylvania and New Jersey. The company said LIBERTY now has accounts across seven Eastern U.S. states. - source: globenewswire.com
Microbot Medical adds first Michigan LIBERTY healthcare-system customer - 2026-06-09 - Market Signal - Microbot Medical announced the first Michigan healthcare-system adoption of its LIBERTY endovascular robotic system. The company described the customer as one of Michigan’s largest healthcare systems. The adoption followed North… - source: ir.microbotmedical.com
Microbot Medical starts U.S. limited market release for LIBERTY - 2025-11-05 - Product Launch - LIBERTY became commercially available in the U.S. through selected high-procedure-volume regions. The company said the launch followed commercial-team hiring and a third-party logistics partnership. The product gives The company… - source: ir.microbotmedical.com
Microbot Medical receives FDA clearance for LIBERTY endovascular robot - 2025-09-08 - Regulatory - Microbot Medical received FDA 510(k) clearance for the LIBERTY endovascular robotic system. The clearance moved LIBERTY from development into a regulated commercial pathway for endovascular procedures. The event anchors Microbot as… - source: ir.microbotmedical.com